# The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx)

> **NIH NIH U54** · UNIVERSITY OF SOUTHERN CALIFORNIA · 2021 · $37,498

## Abstract

PROJECT SUMMARY
The EpiBioS4Rx program requires long term storage, archival, and distribution of biological samples. These
activities have been deemed to be beyond the capacity of our center to perform at a professional level, with
necessary quality assurances and fail-safes of sample storage. Thus, we sought a professional resource for this,
namely BioSEND. BioSEND is the National Institute of Neurological Disorders and Stroke (NINDS) biomarker
repository, which houses biospecimens collected as part of biomarker studies supported by the NINDS.
BioSEND will complete all biorepository needs for this study and supply kits, supplemental kits, transportation,
plasma receipt and processing, buffy coat intake, extraction and quality control, and hemoglobin quality control.
This will be set up as fee for service and we will monitor all services in conjunction with UCLA.

## Key facts

- **NIH application ID:** 10368714
- **Project number:** 3U54NS100064-05S1
- **Recipient organization:** UNIVERSITY OF SOUTHERN CALIFORNIA
- **Principal Investigator:** JEROME NONE ENGEL
- **Activity code:** U54 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $37,498
- **Award type:** 3
- **Project period:** 2020-05-08 → 2022-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10368714

## Citation

> US National Institutes of Health, RePORTER application 10368714, The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx) (3U54NS100064-05S1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10368714. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*